Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
53,512,954,839
-
Total 13F shares
-
1,170,067
-
Share change
-
+619,327
-
Total reported value
-
$1,181,319
-
Price per share
-
$1.01
-
Number of holders
-
16
-
Value change
-
+$593,370
-
Number of buys
-
5
-
Number of sells
-
5
Institutional Holders of Akari Therapeutics Plc - Ordinary Shares, $0.0001 par value (AKTX) as of Q3 2025
As of 30 Sep 2025 Akari Therapeutics Plc - Ordinary Shares, $0.0001 par value (AKTX) had 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,170,067 shares of stock of the company.
Largest 10 holders included Cresset Asset Management, LLC, Palo Alto Investors LP, HighTower Advisors, LLC, Omnia Family Wealth, LLC, Cerity Partners LLC, Virtu Financial LLC, TWO SIGMA SECURITIES, LLC, Independent Advisor Alliance, Accent Capital Management, LLC, and NewEdge Advisors, LLC.
This table shows 16 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.